Andrea Pozo-Rodrigálvarez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrea Pozo-Rodrigálvarez has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ana Patricia Fernández
Instituto Cajal, Consejo Superior de Investigaciones Científicas, Madrid, Spain
3 shared publications Julia Serrano
3 shared publications- Ricardo Martínez-Murillo
Neurovascular Research Group, Department of Translational Neuroscience, Instituto Cajal, CSIC, 28002 Madrid, Spain
2 shared publications Ana Gradillas
1 shared publicationDavid Dávila
CIBERNED, 28002, Madrid, Spain
1 shared publicationElsa Cortés-Montero
Department of Molecular, Cellular and Developmental Neurobiology, Laboratory of Neuropharmacology, Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
1 shared publication
Latest Publications
- Open Access
- 10 October 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (34) , 35458-35477
The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders
The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders
- 10 October 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (34) , 35458-35477
Open AccessThe ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders
The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders
- Open Access
- 28 January 2014
- Published by F1000 Research Ltd in F1000Research
- Vol. 3
Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury
Oxidative stress is a proposed mechanism in brain aging, making the study of its regulatory processes an important aspect of current neurobiological research. In this regard, the role of the aging regulator insulin-like growth factor I (IGF-I) in brain responses to oxidative stress remains elusive as both beneficial and detrimental actions have been ascribed to this growth factor. Because astrocytes protect neurons against oxidative injury, we explored whether IGF-I participates in astrocyte neuroprotection and found that blockade of the IGF-I receptor in astrocytes abrogated their rescuing effect on neurons.We found that IGF-I directly protects astrocytes against oxidative stress (H2O2). Indeed, in astrocytes but not in neurons, IGF-I decreases the pro-oxidant protein thioredoxin-interacting protein 1 and normalizes the levels of reactive oxygen species. Furthermore, IGF-I cooperates with trophic signals produced by astrocytes in response to H2O2 such as stem cell factor (SCF) to protect...
- 28 January 2014
- Published by F1000 Research Ltd in F1000Research
- Vol. 3
Open AccessAstrocytes require insulin-like growth factor I to protect neurons against oxidative injury
Oxidative stress is a proposed mechanism in brain aging, making the study of its regulatory processes an important aspect of current neurobiological research. In this regard, the role of the aging regulator insulin-like growth factor I (IGF-I) in brain responses to oxidative stress remains elusive as both beneficial and detrimental actions have been ascribed to this growth factor. Because astrocytes protect neurons against oxidative injury, we explored whether IGF-I participates in astrocyte neuroprotection and found that blockade of the IGF-I receptor in astrocytes abrogated their rescuing effect on neurons.We found that IGF-I directly protects astrocytes against oxidative stress (H2O2). Indeed, in astrocytes but not in neurons, IGF-I decreases the pro-oxidant protein thioredoxin-interacting protein 1 and normalizes the levels of reactive oxygen species. Furthermore, IGF-I cooperates with trophic signals produced by astrocytes in response to H2O2 such as stem cell factor (SCF) to protect...
- 1 August 2012
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 54, 439-446
New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714
- 1 August 2012
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 54, 439-446
New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714
- Open Access
- 1 January 2012
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 6, 24602
Neural differentiation of transplanted neural stem cells in a rat model of striatal lacunar infarction: light and electron microscopic observations
The increased risk and prevalence of lacunar stroke and Parkinson's disease makes the search for better experimental models an important requirement for translational research. In this study we assess ischemic damage of the nigrostriatal pathway in a model of lacunar stroke evoked by damaging the perforating arteries in the territory of the substantia nigra of the rat after stereotaxic administration of endothelin-1, a potent vasoconstrictor peptide. We hypothesized that transplantation of neural stem cells (NSCs) with the capacity of differentiating into diverse cell types such as neurons and glia, but with limited proliferation potential, would constitute an alternative and/or adjuvant therapy for lacunar stroke. These cells showed neuritogenic activity in vitro and a high potential for neural differentiation. Light and electron microscopy immunocytochemistry was used to characterize green fluorescent-derived neurons. 48h after endothelin-1 injection, we characterized an area of selective degeneration of dopaminergic neurons within the nigrostriatal pathway characterised with tissue necrosis and glial scar formation, with subsequent behavioral signs of Parkinsonism. Light microscopy showed that grafted cells within the striatal infarction zone differentiated with a high yield into mature glial cells (GFAP-positive) and into neurons of diverse neurotransmitter-striatal subtypes, suggesting that they were functional. Electron microscopy revealed that NSCs-derived neurons integrated into the host circuitry establishing synaptic contacts, mostly of the asymmetric type. Astrocytes were closely associated with normal small-sized blood vessels in the area of infarct, suggesting their implication in angiogenesis during recovery from stroke. Our results encourage the use of NSCs as a cell-replacement therapy for the treatment of human vascular Parkinsonism.
- 1 January 2012
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 6, 24602
Open AccessNeural differentiation of transplanted neural stem cells in a rat model of striatal lacunar infarction: light and electron microscopic observations
The increased risk and prevalence of lacunar stroke and Parkinson's disease makes the search for better experimental models an important requirement for translational research. In this study we assess ischemic damage of the nigrostriatal pathway in a model of lacunar stroke evoked by damaging the perforating arteries in the territory of the substantia nigra of the rat after stereotaxic administration of endothelin-1, a potent vasoconstrictor peptide. We hypothesized that transplantation of neural stem cells (NSCs) with the capacity of differentiating into diverse cell types such as neurons and glia, but with limited proliferation potential, would constitute an alternative and/or adjuvant therapy for lacunar stroke. These cells showed neuritogenic activity in vitro and a high potential for neural differentiation. Light and electron microscopy immunocytochemistry was used to characterize green fluorescent-derived neurons. 48h after endothelin-1 injection, we characterized an area of selective degeneration of dopaminergic neurons within the nigrostriatal pathway characterised with tissue necrosis and glial scar formation, with subsequent behavioral signs of Parkinsonism. Light microscopy showed that grafted cells within the striatal infarction zone differentiated with a high yield into mature glial cells (GFAP-positive) and into neurons of diverse neurotransmitter-striatal subtypes, suggesting that they were functional. Electron microscopy revealed that NSCs-derived neurons integrated into the host circuitry establishing synaptic contacts, mostly of the asymmetric type. Astrocytes were closely associated with normal small-sized blood vessels in the area of infarct, suggesting their implication in angiogenesis during recovery from stroke. Our results encourage the use of NSCs as a cell-replacement therapy for the treatment of human vascular Parkinsonism.
- 1 November 2011
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 10 (7) , 820-833
Adrenomedullin and nitric oxide: implications for the etiology and treatment of primary brain tumors.
Abstract: Gliomas, defined as tumors of glial origin, represent between 2-5% of all adult cancer and comprise the majority of primary brain tumors. Infiltrating gliomas, with an incidence of more than 40% of brain tumors, are the most common and destructive primary brain tumors for which conventional therapies have not significantly improved patient outcome. In fact, patients suffering from malignant gliomas have poor prognoses and the majority have local tumor recurrence after treatment. Tumor growth and spread of tumor cells depend basically upon angiogenesis and on functional abnormalities of tumor cells in the control of apoptosis, as they are paradigmatic for their intrinsic resistance to multiple pro-apoptotic stimuli. Therefore, promising strategies for treatment of brain cancer would be directed to appropriate neutralization of angiogenesis and sensibilization of cancer cells to undergo apoptosis. However, despite advances in this field, high-grade gliomas remain incurable with survival often measured in months. Therefore there is a need to discover new and more potent cocktails of drugs to target the key molecular pathways involved in glioma angiogenesis and apoptosis. This review deals with the effects of two groups of molecules closely linked to neural tissue, which have been implicated in brain cancer: nitric oxide and peptides of the adrenomedullin family. These molecules exert vasodilatory and proangiogenic actions. Adrenomedullin also has antiapoptotic functions at appropriate concentrations. The inhibition of these functions, in the case of cancer, may provide new pharmacological strategies in the treatment of this disease.
- 1 November 2011
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 10 (7) , 820-833
Adrenomedullin and nitric oxide: implications for the etiology and treatment of primary brain tumors.
Abstract: Gliomas, defined as tumors of glial origin, represent between 2-5% of all adult cancer and comprise the majority of primary brain tumors. Infiltrating gliomas, with an incidence of more than 40% of brain tumors, are the most common and destructive primary brain tumors for which conventional therapies have not significantly improved patient outcome. In fact, patients suffering from malignant gliomas have poor prognoses and the majority have local tumor recurrence after treatment. Tumor growth and spread of tumor cells depend basically upon angiogenesis and on functional abnormalities of tumor cells in the control of apoptosis, as they are paradigmatic for their intrinsic resistance to multiple pro-apoptotic stimuli. Therefore, promising strategies for treatment of brain cancer would be directed to appropriate neutralization of angiogenesis and sensibilization of cancer cells to undergo apoptosis. However, despite advances in this field, high-grade gliomas remain incurable with survival often measured in months. Therefore there is a need to discover new and more potent cocktails of drugs to target the key molecular pathways involved in glioma angiogenesis and apoptosis. This review deals with the effects of two groups of molecules closely linked to neural tissue, which have been implicated in brain cancer: nitric oxide and peptides of the adrenomedullin family. These molecules exert vasodilatory and proangiogenic actions. Adrenomedullin also has antiapoptotic functions at appropriate concentrations. The inhibition of these functions, in the case of cancer, may provide new pharmacological strategies in the treatment of this disease.